...steps by Gilead Sciences Inc. could include testing the compound in animal models of HCV. ContraVir Pharmaceuticals...

...Pharmaceuticals Inc. (NASDAQ:DFFN) named William Hornung CBO, a newly created position. He was CFO at ContraVir Pharmaceuticals...

...they want to build. For instance, Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY), Spring Bank Pharmaceuticals Inc. (NASDAQ:SBPH), ContraVir Pharmaceuticals...
...I/II) 1 Altimmune Inc. (NASDAQ:ALT) CD4 and CD8 T cell booster HepTcell (Ph I) 1 ContraVir Pharmaceuticals...
...functional cure of hepatitis B.” Clinical Liver Disease (2016) Erin McCallister, Senior Editor Arbutus Biopharma Corp. Assembly Biosciences Inc. Hepion Pharmaceuticals Inc. Gilead...

...4/28/17 $15.0 $73.7 $95.8 30% Verona Pharma plc (LSE:VRP; NASDAQ:VRNA) 4/27/17 $87.8 $177.0 $152.9 -14% ContraVir Pharmaceuticals...

...the product from Chimerix (see BioCentury, Dec. 22, 2014 ). Chimerix Inc. (NASDAQ:CMRX), Durham, N.C. ContraVir Pharmaceuticals...
...Endpoint: Safety and antiviral activity; pharmacokinetics Status: Interim Phase IIa data Milestone: NA Jaime De Leon TXL Chimerix Inc. Hepion Pharmaceuticals Inc. Viral...

...Infectious disease company ContraVir Pharmaceuticals Inc. (NASDAQ:CTRV) raised $12 million on April 25 through the sale of...
...in a follow-on underwritten by Canaccord Genuity and Maxim. ContraVir Pharmaceuticals Inc. (NASDAQ:CTRV), New York, N.Y. Mary Romeo Hepion Pharmaceuticals Inc....

...vehicle. Next steps could include identifying and testing additional CYPA inhibitors in models of ALS. ContraVir Pharmaceuticals...

...have primarily pursued cyclophilin inhibition for anti-infectives, in addition to immunosuppression with ciclosporin. These include ContraVir Pharmaceuticals...
...NVP015 in 2018 or 2019. Companies and Institutions Mentioned Arbutus Biopharma Corp. (NASDAQ:ABUS), Burnaby, B.C. ContraVir Pharmaceuticals...

...rights to CMX157 from Chimerix (see BioCentury, Dec. 22, 2014). Chimerix Inc. (NASDAQ:CMRX), Durham, N.C. ContraVir Pharmaceuticals...

...analog tenofovir, from Chimerix Inc. (NASDAQ:CMRX, Durham, N.C.). Ciclofilin Pharmaceuticals Inc. , San Diego, Calif. ContraVir Pharmaceuticals...